Global Next Generation Sequencing (NGS) Solution Market Growth (Status and Outlook) 2026-2032
The global Next Generation Sequencing (NGS) Solution market size is predicted to grow from US$ 5400 million in 2025 to US$ 14960 million in 2032; it is expected to grow at a CAGR of 16.0% from 2026 to 2032.
Next Generation Sequencing (NGS), also known as high-throughput sequencing, refers to advanced genomic technologies that enable the rapid and cost-effective sequencing of DNA or RNA molecules. NGS solutions have revolutionized the field of genomics and have significant applications in various areas of life sciences, including medical research, diagnostics, personalized medicine, agriculture, and environmental studies.
The global market for Next Generation Sequencing (NGS) solutions has experienced significant growth in recent years, driven by the increasing adoption of NGS technologies in various research and clinical applications. NGS has revolutionized genomics research, personalized medicine, and diagnostics, making it one of the most impactful technologies in the life sciences industry. Continuous innovations in NGS platforms, sequencing chemistries, and bioinformatics tools have improved sequencing accuracy, speed, and data analysis capabilities. The increasing focus on understanding the genetic basis of diseases, population genomics, and agricultural genomics has driven the demand for NGS solutions. The United States and Canada are major contributors to the global NGS market due to their well-established research infrastructure and a large number of NGS-based research projects. European countries, including the United Kingdom, Germany, and France, have seen significant NGS adoption in both research and clinical applications. Countries like China, Japan, and India have witnessed rapid growth in the NGS market, driven by increasing research investments and government initiatives. The global market for NGS solutions is expected to continue its growth trajectory in the coming years. The increasing adoption of NGS in clinical diagnostics, precision medicine, and agriculture is likely to drive further market expansion. Moreover, ongoing advancements in NGS technologies, such as single-cell sequencing and long-read sequencing, will continue to unlock new research possibilities and applications, expanding the reach of NGS into various scientific disciplines.
LPI (LP Information)' newest research report, the “Next Generation Sequencing (NGS) Solution Industry Forecast” looks at past sales and reviews total world Next Generation Sequencing (NGS) Solution sales in 2025, providing a comprehensive analysis by region and market sector of projected Next Generation Sequencing (NGS) Solution sales for 2026 through 2032. With Next Generation Sequencing (NGS) Solution sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Next Generation Sequencing (NGS) Solution industry.
This Insight Report provides a comprehensive analysis of the global Next Generation Sequencing (NGS) Solution landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Next Generation Sequencing (NGS) Solution portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Next Generation Sequencing (NGS) Solution market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Next Generation Sequencing (NGS) Solution and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Next Generation Sequencing (NGS) Solution.
This report presents a comprehensive overview, market shares, and growth opportunities of Next Generation Sequencing (NGS) Solution market by product type, application, key players and key regions and countries.
Next Generation Sequencing (NGS), also known as high-throughput sequencing, refers to advanced genomic technologies that enable the rapid and cost-effective sequencing of DNA or RNA molecules. NGS solutions have revolutionized the field of genomics and have significant applications in various areas of life sciences, including medical research, diagnostics, personalized medicine, agriculture, and environmental studies.
The global market for Next Generation Sequencing (NGS) solutions has experienced significant growth in recent years, driven by the increasing adoption of NGS technologies in various research and clinical applications. NGS has revolutionized genomics research, personalized medicine, and diagnostics, making it one of the most impactful technologies in the life sciences industry. Continuous innovations in NGS platforms, sequencing chemistries, and bioinformatics tools have improved sequencing accuracy, speed, and data analysis capabilities. The increasing focus on understanding the genetic basis of diseases, population genomics, and agricultural genomics has driven the demand for NGS solutions. The United States and Canada are major contributors to the global NGS market due to their well-established research infrastructure and a large number of NGS-based research projects. European countries, including the United Kingdom, Germany, and France, have seen significant NGS adoption in both research and clinical applications. Countries like China, Japan, and India have witnessed rapid growth in the NGS market, driven by increasing research investments and government initiatives. The global market for NGS solutions is expected to continue its growth trajectory in the coming years. The increasing adoption of NGS in clinical diagnostics, precision medicine, and agriculture is likely to drive further market expansion. Moreover, ongoing advancements in NGS technologies, such as single-cell sequencing and long-read sequencing, will continue to unlock new research possibilities and applications, expanding the reach of NGS into various scientific disciplines.
LPI (LP Information)' newest research report, the “Next Generation Sequencing (NGS) Solution Industry Forecast” looks at past sales and reviews total world Next Generation Sequencing (NGS) Solution sales in 2025, providing a comprehensive analysis by region and market sector of projected Next Generation Sequencing (NGS) Solution sales for 2026 through 2032. With Next Generation Sequencing (NGS) Solution sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Next Generation Sequencing (NGS) Solution industry.
This Insight Report provides a comprehensive analysis of the global Next Generation Sequencing (NGS) Solution landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Next Generation Sequencing (NGS) Solution portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Next Generation Sequencing (NGS) Solution market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Next Generation Sequencing (NGS) Solution and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Next Generation Sequencing (NGS) Solution.
This report presents a comprehensive overview, market shares, and growth opportunities of Next Generation Sequencing (NGS) Solution market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Whole Genome Sequencing
- Whole Exome Sequencing
- Targeted Sequencing and Resequencing Centrifuges
Segmentation by Application:
- Sporadic Cancer
- Inherited Cancer
- Companion Diagnostics
- Others
This report also splits the market by region:
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Eurofins Scientific
- Illumina
- PerkinElmer
- Thermo Fisher Scientific
- Roche Holding
- Agilent Technologies
- Myriad Genetics
- Foundation Medicine
- Oxford Nanopore Technologies
- Pacific Biosciences
- Paradigm Diagnostics
- BGI Group
- Caris Life Sciences
- Partek
- Natera
- LabCorp
- Macrogen
- Genotypic Technology
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Next Generation Sequencing (NGS) Solution Market Size (2021-2032)
2.1.2 Next Generation Sequencing (NGS) Solution Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Next Generation Sequencing (NGS) Solution by Country/Region (2021, 2025 & 2032)
2.2 Next Generation Sequencing (NGS) Solution Segment by Type
2.2.1 Whole Genome Sequencing
2.2.2 Whole Exome Sequencing
2.2.3 Targeted Sequencing and Resequencing Centrifuges
2.2.4 Next Generation Sequencing (NGS) Solution Market Size by Type
2.2.4.1 Next Generation Sequencing (NGS) Solution Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.4.2 Global Next Generation Sequencing (NGS) Solution Market Size Market Share by Type (2021-2026)
2.3 Next Generation Sequencing (NGS) Solution Segment by Application
2.3.1 Sporadic Cancer
2.3.2 Inherited Cancer
2.3.3 Companion Diagnostics
2.3.4 Others
2.3.5 Next Generation Sequencing (NGS) Solution Market Size by Application
2.3.5.1 Next Generation Sequencing (NGS) Solution Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.5.2 Global Next Generation Sequencing (NGS) Solution Market Size Market Share by Application (2021-2026)
3 NEXT GENERATION SEQUENCING (NGS) SOLUTION MARKET SIZE BY PLAYER
3.1 Next Generation Sequencing (NGS) Solution Market Size Market Share by Player
3.1.1 Global Next Generation Sequencing (NGS) Solution Revenue by Player (2021-2026)
3.1.2 Global Next Generation Sequencing (NGS) Solution Revenue Market Share by Player (2021-2026)
3.2 Global Next Generation Sequencing (NGS) Solution Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 NEXT GENERATION SEQUENCING (NGS) SOLUTION BY REGION
4.1 Next Generation Sequencing (NGS) Solution Market Size by Region (2021-2026)
4.2 Global Next Generation Sequencing (NGS) Solution Annual Revenue by Country/Region (2021-2026)
4.3 Americas Next Generation Sequencing (NGS) Solution Market Size Growth (2021-2026)
4.4 APAC Next Generation Sequencing (NGS) Solution Market Size Growth (2021-2026)
4.5 Europe Next Generation Sequencing (NGS) Solution Market Size Growth (2021-2026)
4.6 Middle East & Africa Next Generation Sequencing (NGS) Solution Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Next Generation Sequencing (NGS) Solution Market Size by Country (2021-2026)
5.2 Americas Next Generation Sequencing (NGS) Solution Market Size by Type (2021-2026)
5.3 Americas Next Generation Sequencing (NGS) Solution Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Next Generation Sequencing (NGS) Solution Market Size by Region (2021-2026)
6.2 APAC Next Generation Sequencing (NGS) Solution Market Size by Type (2021-2026)
6.3 APAC Next Generation Sequencing (NGS) Solution Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Next Generation Sequencing (NGS) Solution Market Size by Country (2021-2026)
7.2 Europe Next Generation Sequencing (NGS) Solution Market Size by Type (2021-2026)
7.3 Europe Next Generation Sequencing (NGS) Solution Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Next Generation Sequencing (NGS) Solution by Region (2021-2026)
8.2 Middle East & Africa Next Generation Sequencing (NGS) Solution Market Size by Type (2021-2026)
8.3 Middle East & Africa Next Generation Sequencing (NGS) Solution Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL NEXT GENERATION SEQUENCING (NGS) SOLUTION MARKET FORECAST
10.1 Global Next Generation Sequencing (NGS) Solution Forecast by Region (2027-2032)
10.1.1 Global Next Generation Sequencing (NGS) Solution Forecast by Region (2027-2032)
10.1.2 Americas Next Generation Sequencing (NGS) Solution Forecast
10.1.3 APAC Next Generation Sequencing (NGS) Solution Forecast
10.1.4 Europe Next Generation Sequencing (NGS) Solution Forecast
10.1.5 Middle East & Africa Next Generation Sequencing (NGS) Solution Forecast
10.2 Americas Next Generation Sequencing (NGS) Solution Forecast by Country (2027-2032)
10.2.1 United States Market Next Generation Sequencing (NGS) Solution Forecast
10.2.2 Canada Market Next Generation Sequencing (NGS) Solution Forecast
10.2.3 Mexico Market Next Generation Sequencing (NGS) Solution Forecast
10.2.4 Brazil Market Next Generation Sequencing (NGS) Solution Forecast
10.3 APAC Next Generation Sequencing (NGS) Solution Forecast by Region (2027-2032)
10.3.1 China Next Generation Sequencing (NGS) Solution Market Forecast
10.3.2 Japan Market Next Generation Sequencing (NGS) Solution Forecast
10.3.3 Korea Market Next Generation Sequencing (NGS) Solution Forecast
10.3.4 Southeast Asia Market Next Generation Sequencing (NGS) Solution Forecast
10.3.5 India Market Next Generation Sequencing (NGS) Solution Forecast
10.3.6 Australia Market Next Generation Sequencing (NGS) Solution Forecast
10.4 Europe Next Generation Sequencing (NGS) Solution Forecast by Country (2027-2032)
10.4.1 Germany Market Next Generation Sequencing (NGS) Solution Forecast
10.4.2 France Market Next Generation Sequencing (NGS) Solution Forecast
10.4.3 UK Market Next Generation Sequencing (NGS) Solution Forecast
10.4.4 Italy Market Next Generation Sequencing (NGS) Solution Forecast
10.4.5 Russia Market Next Generation Sequencing (NGS) Solution Forecast
10.5 Middle East & Africa Next Generation Sequencing (NGS) Solution Forecast by Region (2027-2032)
10.5.1 Egypt Market Next Generation Sequencing (NGS) Solution Forecast
10.5.2 South Africa Market Next Generation Sequencing (NGS) Solution Forecast
10.5.3 Israel Market Next Generation Sequencing (NGS) Solution Forecast
10.5.4 Turkey Market Next Generation Sequencing (NGS) Solution Forecast
10.6 Global Next Generation Sequencing (NGS) Solution Forecast by Type (2027-2032)
10.7 Global Next Generation Sequencing (NGS) Solution Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Next Generation Sequencing (NGS) Solution Forecast
11 KEY PLAYERS ANALYSIS
11.1 Eurofins Scientific
11.1.1 Eurofins Scientific Company Information
11.1.2 Eurofins Scientific Next Generation Sequencing (NGS) Solution Product Offered
11.1.3 Eurofins Scientific Next Generation Sequencing (NGS) Solution Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Eurofins Scientific Main Business Overview
11.1.5 Eurofins Scientific Latest Developments
11.2 Illumina
11.2.1 Illumina Company Information
11.2.2 Illumina Next Generation Sequencing (NGS) Solution Product Offered
11.2.3 Illumina Next Generation Sequencing (NGS) Solution Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Illumina Main Business Overview
11.2.5 Illumina Latest Developments
11.3 PerkinElmer
11.3.1 PerkinElmer Company Information
11.3.2 PerkinElmer Next Generation Sequencing (NGS) Solution Product Offered
11.3.3 PerkinElmer Next Generation Sequencing (NGS) Solution Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 PerkinElmer Main Business Overview
11.3.5 PerkinElmer Latest Developments
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Company Information
11.4.2 Thermo Fisher Scientific Next Generation Sequencing (NGS) Solution Product Offered
11.4.3 Thermo Fisher Scientific Next Generation Sequencing (NGS) Solution Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Thermo Fisher Scientific Main Business Overview
11.4.5 Thermo Fisher Scientific Latest Developments
11.5 Roche Holding
11.5.1 Roche Holding Company Information
11.5.2 Roche Holding Next Generation Sequencing (NGS) Solution Product Offered
11.5.3 Roche Holding Next Generation Sequencing (NGS) Solution Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Roche Holding Main Business Overview
11.5.5 Roche Holding Latest Developments
11.6 Agilent Technologies
11.6.1 Agilent Technologies Company Information
11.6.2 Agilent Technologies Next Generation Sequencing (NGS) Solution Product Offered
11.6.3 Agilent Technologies Next Generation Sequencing (NGS) Solution Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Agilent Technologies Main Business Overview
11.6.5 Agilent Technologies Latest Developments
11.7 Myriad Genetics
11.7.1 Myriad Genetics Company Information
11.7.2 Myriad Genetics Next Generation Sequencing (NGS) Solution Product Offered
11.7.3 Myriad Genetics Next Generation Sequencing (NGS) Solution Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Myriad Genetics Main Business Overview
11.7.5 Myriad Genetics Latest Developments
11.8 Foundation Medicine
11.8.1 Foundation Medicine Company Information
11.8.2 Foundation Medicine Next Generation Sequencing (NGS) Solution Product Offered
11.8.3 Foundation Medicine Next Generation Sequencing (NGS) Solution Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Foundation Medicine Main Business Overview
11.8.5 Foundation Medicine Latest Developments
11.9 Oxford Nanopore Technologies
11.9.1 Oxford Nanopore Technologies Company Information
11.9.2 Oxford Nanopore Technologies Next Generation Sequencing (NGS) Solution Product Offered
11.9.3 Oxford Nanopore Technologies Next Generation Sequencing (NGS) Solution Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Oxford Nanopore Technologies Main Business Overview
11.9.5 Oxford Nanopore Technologies Latest Developments
11.10 Pacific Biosciences
11.10.1 Pacific Biosciences Company Information
11.10.2 Pacific Biosciences Next Generation Sequencing (NGS) Solution Product Offered
11.10.3 Pacific Biosciences Next Generation Sequencing (NGS) Solution Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Pacific Biosciences Main Business Overview
11.10.5 Pacific Biosciences Latest Developments
11.11 Paradigm Diagnostics
11.11.1 Paradigm Diagnostics Company Information
11.11.2 Paradigm Diagnostics Next Generation Sequencing (NGS) Solution Product Offered
11.11.3 Paradigm Diagnostics Next Generation Sequencing (NGS) Solution Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Paradigm Diagnostics Main Business Overview
11.11.5 Paradigm Diagnostics Latest Developments
11.12 BGI Group
11.12.1 BGI Group Company Information
11.12.2 BGI Group Next Generation Sequencing (NGS) Solution Product Offered
11.12.3 BGI Group Next Generation Sequencing (NGS) Solution Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 BGI Group Main Business Overview
11.12.5 BGI Group Latest Developments
11.13 Caris Life Sciences
11.13.1 Caris Life Sciences Company Information
11.13.2 Caris Life Sciences Next Generation Sequencing (NGS) Solution Product Offered
11.13.3 Caris Life Sciences Next Generation Sequencing (NGS) Solution Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Caris Life Sciences Main Business Overview
11.13.5 Caris Life Sciences Latest Developments
11.14 Partek
11.14.1 Partek Company Information
11.14.2 Partek Next Generation Sequencing (NGS) Solution Product Offered
11.14.3 Partek Next Generation Sequencing (NGS) Solution Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Partek Main Business Overview
11.14.5 Partek Latest Developments
11.15 Natera
11.15.1 Natera Company Information
11.15.2 Natera Next Generation Sequencing (NGS) Solution Product Offered
11.15.3 Natera Next Generation Sequencing (NGS) Solution Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 Natera Main Business Overview
11.15.5 Natera Latest Developments
11.16 LabCorp
11.16.1 LabCorp Company Information
11.16.2 LabCorp Next Generation Sequencing (NGS) Solution Product Offered
11.16.3 LabCorp Next Generation Sequencing (NGS) Solution Revenue, Gross Margin and Market Share (2021-2026)
11.16.4 LabCorp Main Business Overview
11.16.5 LabCorp Latest Developments
11.17 Macrogen
11.17.1 Macrogen Company Information
11.17.2 Macrogen Next Generation Sequencing (NGS) Solution Product Offered
11.17.3 Macrogen Next Generation Sequencing (NGS) Solution Revenue, Gross Margin and Market Share (2021-2026)
11.17.4 Macrogen Main Business Overview
11.17.5 Macrogen Latest Developments
11.18 Genotypic Technology
11.18.1 Genotypic Technology Company Information
11.18.2 Genotypic Technology Next Generation Sequencing (NGS) Solution Product Offered
11.18.3 Genotypic Technology Next Generation Sequencing (NGS) Solution Revenue, Gross Margin and Market Share (2021-2026)
11.18.4 Genotypic Technology Main Business Overview
11.18.5 Genotypic Technology Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Next Generation Sequencing (NGS) Solution Market Size (2021-2032)
2.1.2 Next Generation Sequencing (NGS) Solution Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Next Generation Sequencing (NGS) Solution by Country/Region (2021, 2025 & 2032)
2.2 Next Generation Sequencing (NGS) Solution Segment by Type
2.2.1 Whole Genome Sequencing
2.2.2 Whole Exome Sequencing
2.2.3 Targeted Sequencing and Resequencing Centrifuges
2.2.4 Next Generation Sequencing (NGS) Solution Market Size by Type
2.2.4.1 Next Generation Sequencing (NGS) Solution Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.4.2 Global Next Generation Sequencing (NGS) Solution Market Size Market Share by Type (2021-2026)
2.3 Next Generation Sequencing (NGS) Solution Segment by Application
2.3.1 Sporadic Cancer
2.3.2 Inherited Cancer
2.3.3 Companion Diagnostics
2.3.4 Others
2.3.5 Next Generation Sequencing (NGS) Solution Market Size by Application
2.3.5.1 Next Generation Sequencing (NGS) Solution Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.5.2 Global Next Generation Sequencing (NGS) Solution Market Size Market Share by Application (2021-2026)
3 NEXT GENERATION SEQUENCING (NGS) SOLUTION MARKET SIZE BY PLAYER
3.1 Next Generation Sequencing (NGS) Solution Market Size Market Share by Player
3.1.1 Global Next Generation Sequencing (NGS) Solution Revenue by Player (2021-2026)
3.1.2 Global Next Generation Sequencing (NGS) Solution Revenue Market Share by Player (2021-2026)
3.2 Global Next Generation Sequencing (NGS) Solution Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 NEXT GENERATION SEQUENCING (NGS) SOLUTION BY REGION
4.1 Next Generation Sequencing (NGS) Solution Market Size by Region (2021-2026)
4.2 Global Next Generation Sequencing (NGS) Solution Annual Revenue by Country/Region (2021-2026)
4.3 Americas Next Generation Sequencing (NGS) Solution Market Size Growth (2021-2026)
4.4 APAC Next Generation Sequencing (NGS) Solution Market Size Growth (2021-2026)
4.5 Europe Next Generation Sequencing (NGS) Solution Market Size Growth (2021-2026)
4.6 Middle East & Africa Next Generation Sequencing (NGS) Solution Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Next Generation Sequencing (NGS) Solution Market Size by Country (2021-2026)
5.2 Americas Next Generation Sequencing (NGS) Solution Market Size by Type (2021-2026)
5.3 Americas Next Generation Sequencing (NGS) Solution Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Next Generation Sequencing (NGS) Solution Market Size by Region (2021-2026)
6.2 APAC Next Generation Sequencing (NGS) Solution Market Size by Type (2021-2026)
6.3 APAC Next Generation Sequencing (NGS) Solution Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Next Generation Sequencing (NGS) Solution Market Size by Country (2021-2026)
7.2 Europe Next Generation Sequencing (NGS) Solution Market Size by Type (2021-2026)
7.3 Europe Next Generation Sequencing (NGS) Solution Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Next Generation Sequencing (NGS) Solution by Region (2021-2026)
8.2 Middle East & Africa Next Generation Sequencing (NGS) Solution Market Size by Type (2021-2026)
8.3 Middle East & Africa Next Generation Sequencing (NGS) Solution Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL NEXT GENERATION SEQUENCING (NGS) SOLUTION MARKET FORECAST
10.1 Global Next Generation Sequencing (NGS) Solution Forecast by Region (2027-2032)
10.1.1 Global Next Generation Sequencing (NGS) Solution Forecast by Region (2027-2032)
10.1.2 Americas Next Generation Sequencing (NGS) Solution Forecast
10.1.3 APAC Next Generation Sequencing (NGS) Solution Forecast
10.1.4 Europe Next Generation Sequencing (NGS) Solution Forecast
10.1.5 Middle East & Africa Next Generation Sequencing (NGS) Solution Forecast
10.2 Americas Next Generation Sequencing (NGS) Solution Forecast by Country (2027-2032)
10.2.1 United States Market Next Generation Sequencing (NGS) Solution Forecast
10.2.2 Canada Market Next Generation Sequencing (NGS) Solution Forecast
10.2.3 Mexico Market Next Generation Sequencing (NGS) Solution Forecast
10.2.4 Brazil Market Next Generation Sequencing (NGS) Solution Forecast
10.3 APAC Next Generation Sequencing (NGS) Solution Forecast by Region (2027-2032)
10.3.1 China Next Generation Sequencing (NGS) Solution Market Forecast
10.3.2 Japan Market Next Generation Sequencing (NGS) Solution Forecast
10.3.3 Korea Market Next Generation Sequencing (NGS) Solution Forecast
10.3.4 Southeast Asia Market Next Generation Sequencing (NGS) Solution Forecast
10.3.5 India Market Next Generation Sequencing (NGS) Solution Forecast
10.3.6 Australia Market Next Generation Sequencing (NGS) Solution Forecast
10.4 Europe Next Generation Sequencing (NGS) Solution Forecast by Country (2027-2032)
10.4.1 Germany Market Next Generation Sequencing (NGS) Solution Forecast
10.4.2 France Market Next Generation Sequencing (NGS) Solution Forecast
10.4.3 UK Market Next Generation Sequencing (NGS) Solution Forecast
10.4.4 Italy Market Next Generation Sequencing (NGS) Solution Forecast
10.4.5 Russia Market Next Generation Sequencing (NGS) Solution Forecast
10.5 Middle East & Africa Next Generation Sequencing (NGS) Solution Forecast by Region (2027-2032)
10.5.1 Egypt Market Next Generation Sequencing (NGS) Solution Forecast
10.5.2 South Africa Market Next Generation Sequencing (NGS) Solution Forecast
10.5.3 Israel Market Next Generation Sequencing (NGS) Solution Forecast
10.5.4 Turkey Market Next Generation Sequencing (NGS) Solution Forecast
10.6 Global Next Generation Sequencing (NGS) Solution Forecast by Type (2027-2032)
10.7 Global Next Generation Sequencing (NGS) Solution Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Next Generation Sequencing (NGS) Solution Forecast
11 KEY PLAYERS ANALYSIS
11.1 Eurofins Scientific
11.1.1 Eurofins Scientific Company Information
11.1.2 Eurofins Scientific Next Generation Sequencing (NGS) Solution Product Offered
11.1.3 Eurofins Scientific Next Generation Sequencing (NGS) Solution Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Eurofins Scientific Main Business Overview
11.1.5 Eurofins Scientific Latest Developments
11.2 Illumina
11.2.1 Illumina Company Information
11.2.2 Illumina Next Generation Sequencing (NGS) Solution Product Offered
11.2.3 Illumina Next Generation Sequencing (NGS) Solution Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Illumina Main Business Overview
11.2.5 Illumina Latest Developments
11.3 PerkinElmer
11.3.1 PerkinElmer Company Information
11.3.2 PerkinElmer Next Generation Sequencing (NGS) Solution Product Offered
11.3.3 PerkinElmer Next Generation Sequencing (NGS) Solution Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 PerkinElmer Main Business Overview
11.3.5 PerkinElmer Latest Developments
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Company Information
11.4.2 Thermo Fisher Scientific Next Generation Sequencing (NGS) Solution Product Offered
11.4.3 Thermo Fisher Scientific Next Generation Sequencing (NGS) Solution Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Thermo Fisher Scientific Main Business Overview
11.4.5 Thermo Fisher Scientific Latest Developments
11.5 Roche Holding
11.5.1 Roche Holding Company Information
11.5.2 Roche Holding Next Generation Sequencing (NGS) Solution Product Offered
11.5.3 Roche Holding Next Generation Sequencing (NGS) Solution Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Roche Holding Main Business Overview
11.5.5 Roche Holding Latest Developments
11.6 Agilent Technologies
11.6.1 Agilent Technologies Company Information
11.6.2 Agilent Technologies Next Generation Sequencing (NGS) Solution Product Offered
11.6.3 Agilent Technologies Next Generation Sequencing (NGS) Solution Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Agilent Technologies Main Business Overview
11.6.5 Agilent Technologies Latest Developments
11.7 Myriad Genetics
11.7.1 Myriad Genetics Company Information
11.7.2 Myriad Genetics Next Generation Sequencing (NGS) Solution Product Offered
11.7.3 Myriad Genetics Next Generation Sequencing (NGS) Solution Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Myriad Genetics Main Business Overview
11.7.5 Myriad Genetics Latest Developments
11.8 Foundation Medicine
11.8.1 Foundation Medicine Company Information
11.8.2 Foundation Medicine Next Generation Sequencing (NGS) Solution Product Offered
11.8.3 Foundation Medicine Next Generation Sequencing (NGS) Solution Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Foundation Medicine Main Business Overview
11.8.5 Foundation Medicine Latest Developments
11.9 Oxford Nanopore Technologies
11.9.1 Oxford Nanopore Technologies Company Information
11.9.2 Oxford Nanopore Technologies Next Generation Sequencing (NGS) Solution Product Offered
11.9.3 Oxford Nanopore Technologies Next Generation Sequencing (NGS) Solution Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Oxford Nanopore Technologies Main Business Overview
11.9.5 Oxford Nanopore Technologies Latest Developments
11.10 Pacific Biosciences
11.10.1 Pacific Biosciences Company Information
11.10.2 Pacific Biosciences Next Generation Sequencing (NGS) Solution Product Offered
11.10.3 Pacific Biosciences Next Generation Sequencing (NGS) Solution Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Pacific Biosciences Main Business Overview
11.10.5 Pacific Biosciences Latest Developments
11.11 Paradigm Diagnostics
11.11.1 Paradigm Diagnostics Company Information
11.11.2 Paradigm Diagnostics Next Generation Sequencing (NGS) Solution Product Offered
11.11.3 Paradigm Diagnostics Next Generation Sequencing (NGS) Solution Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Paradigm Diagnostics Main Business Overview
11.11.5 Paradigm Diagnostics Latest Developments
11.12 BGI Group
11.12.1 BGI Group Company Information
11.12.2 BGI Group Next Generation Sequencing (NGS) Solution Product Offered
11.12.3 BGI Group Next Generation Sequencing (NGS) Solution Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 BGI Group Main Business Overview
11.12.5 BGI Group Latest Developments
11.13 Caris Life Sciences
11.13.1 Caris Life Sciences Company Information
11.13.2 Caris Life Sciences Next Generation Sequencing (NGS) Solution Product Offered
11.13.3 Caris Life Sciences Next Generation Sequencing (NGS) Solution Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Caris Life Sciences Main Business Overview
11.13.5 Caris Life Sciences Latest Developments
11.14 Partek
11.14.1 Partek Company Information
11.14.2 Partek Next Generation Sequencing (NGS) Solution Product Offered
11.14.3 Partek Next Generation Sequencing (NGS) Solution Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Partek Main Business Overview
11.14.5 Partek Latest Developments
11.15 Natera
11.15.1 Natera Company Information
11.15.2 Natera Next Generation Sequencing (NGS) Solution Product Offered
11.15.3 Natera Next Generation Sequencing (NGS) Solution Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 Natera Main Business Overview
11.15.5 Natera Latest Developments
11.16 LabCorp
11.16.1 LabCorp Company Information
11.16.2 LabCorp Next Generation Sequencing (NGS) Solution Product Offered
11.16.3 LabCorp Next Generation Sequencing (NGS) Solution Revenue, Gross Margin and Market Share (2021-2026)
11.16.4 LabCorp Main Business Overview
11.16.5 LabCorp Latest Developments
11.17 Macrogen
11.17.1 Macrogen Company Information
11.17.2 Macrogen Next Generation Sequencing (NGS) Solution Product Offered
11.17.3 Macrogen Next Generation Sequencing (NGS) Solution Revenue, Gross Margin and Market Share (2021-2026)
11.17.4 Macrogen Main Business Overview
11.17.5 Macrogen Latest Developments
11.18 Genotypic Technology
11.18.1 Genotypic Technology Company Information
11.18.2 Genotypic Technology Next Generation Sequencing (NGS) Solution Product Offered
11.18.3 Genotypic Technology Next Generation Sequencing (NGS) Solution Revenue, Gross Margin and Market Share (2021-2026)
11.18.4 Genotypic Technology Main Business Overview
11.18.5 Genotypic Technology Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Next Generation Sequencing (NGS) Solution Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Next Generation Sequencing (NGS) Solution Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Whole Genome Sequencing
Table 4. Major Players of Whole Exome Sequencing
Table 5. Major Players of Targeted Sequencing and Resequencing Centrifuges
Table 6. Next Generation Sequencing (NGS) Solution Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 7. Global Next Generation Sequencing (NGS) Solution Market Size by Type (2021-2026) & ($ millions)
Table 8. Global Next Generation Sequencing (NGS) Solution Market Size Market Share by Type (2021-2026)
Table 9. Next Generation Sequencing (NGS) Solution Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 10. Global Next Generation Sequencing (NGS) Solution Market Size by Application (2021-2026) & ($ millions)
Table 11. Global Next Generation Sequencing (NGS) Solution Market Size Market Share by Application (2021-2026)
Table 12. Global Next Generation Sequencing (NGS) Solution Revenue by Player (2021-2026) & ($ millions)
Table 13. Global Next Generation Sequencing (NGS) Solution Revenue Market Share by Player (2021-2026)
Table 14. Next Generation Sequencing (NGS) Solution Key Players Head office and Products Offered
Table 15. Next Generation Sequencing (NGS) Solution Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Next Generation Sequencing (NGS) Solution Market Size by Region (2021-2026) & ($ millions)
Table 19. Global Next Generation Sequencing (NGS) Solution Market Size Market Share by Region (2021-2026)
Table 20. Global Next Generation Sequencing (NGS) Solution Revenue by Country/Region (2021-2026) & ($ millions)
Table 21. Global Next Generation Sequencing (NGS) Solution Revenue Market Share by Country/Region (2021-2026)
Table 22. Americas Next Generation Sequencing (NGS) Solution Market Size by Country (2021-2026) & ($ millions)
Table 23. Americas Next Generation Sequencing (NGS) Solution Market Size Market Share by Country (2021-2026)
Table 24. Americas Next Generation Sequencing (NGS) Solution Market Size by Type (2021-2026) & ($ millions)
Table 25. Americas Next Generation Sequencing (NGS) Solution Market Size Market Share by Type (2021-2026)
Table 26. Americas Next Generation Sequencing (NGS) Solution Market Size by Application (2021-2026) & ($ millions)
Table 27. Americas Next Generation Sequencing (NGS) Solution Market Size Market Share by Application (2021-2026)
Table 28. APAC Next Generation Sequencing (NGS) Solution Market Size by Region (2021-2026) & ($ millions)
Table 29. APAC Next Generation Sequencing (NGS) Solution Market Size Market Share by Region (2021-2026)
Table 30. APAC Next Generation Sequencing (NGS) Solution Market Size by Type (2021-2026) & ($ millions)
Table 31. APAC Next Generation Sequencing (NGS) Solution Market Size by Application (2021-2026) & ($ millions)
Table 32. Europe Next Generation Sequencing (NGS) Solution Market Size by Country (2021-2026) & ($ millions)
Table 33. Europe Next Generation Sequencing (NGS) Solution Market Size Market Share by Country (2021-2026)
Table 34. Europe Next Generation Sequencing (NGS) Solution Market Size by Type (2021-2026) & ($ millions)
Table 35. Europe Next Generation Sequencing (NGS) Solution Market Size by Application (2021-2026) & ($ millions)
Table 36. Middle East & Africa Next Generation Sequencing (NGS) Solution Market Size by Region (2021-2026) & ($ millions)
Table 37. Middle East & Africa Next Generation Sequencing (NGS) Solution Market Size by Type (2021-2026) & ($ millions)
Table 38. Middle East & Africa Next Generation Sequencing (NGS) Solution Market Size by Application (2021-2026) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Next Generation Sequencing (NGS) Solution
Table 40. Key Market Challenges & Risks of Next Generation Sequencing (NGS) Solution
Table 41. Key Industry Trends of Next Generation Sequencing (NGS) Solution
Table 42. Global Next Generation Sequencing (NGS) Solution Market Size Forecast by Region (2027-2032) & ($ millions)
Table 43. Global Next Generation Sequencing (NGS) Solution Market Size Market Share Forecast by Region (2027-2032)
Table 44. Global Next Generation Sequencing (NGS) Solution Market Size Forecast by Type (2027-2032) & ($ millions)
Table 45. Global Next Generation Sequencing (NGS) Solution Market Size Forecast by Application (2027-2032) & ($ millions)
Table 46. Eurofins Scientific Details, Company Type, Next Generation Sequencing (NGS) Solution Area Served and Its Competitors
Table 47. Eurofins Scientific Next Generation Sequencing (NGS) Solution Product Offered
Table 48. Eurofins Scientific Next Generation Sequencing (NGS) Solution Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 49. Eurofins Scientific Main Business
Table 50. Eurofins Scientific Latest Developments
Table 51. Illumina Details, Company Type, Next Generation Sequencing (NGS) Solution Area Served and Its Competitors
Table 52. Illumina Next Generation Sequencing (NGS) Solution Product Offered
Table 53. Illumina Next Generation Sequencing (NGS) Solution Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 54. Illumina Main Business
Table 55. Illumina Latest Developments
Table 56. PerkinElmer Details, Company Type, Next Generation Sequencing (NGS) Solution Area Served and Its Competitors
Table 57. PerkinElmer Next Generation Sequencing (NGS) Solution Product Offered
Table 58. PerkinElmer Next Generation Sequencing (NGS) Solution Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 59. PerkinElmer Main Business
Table 60. PerkinElmer Latest Developments
Table 61. Thermo Fisher Scientific Details, Company Type, Next Generation Sequencing (NGS) Solution Area Served and Its Competitors
Table 62. Thermo Fisher Scientific Next Generation Sequencing (NGS) Solution Product Offered
Table 63. Thermo Fisher Scientific Next Generation Sequencing (NGS) Solution Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 64. Thermo Fisher Scientific Main Business
Table 65. Thermo Fisher Scientific Latest Developments
Table 66. Roche Holding Details, Company Type, Next Generation Sequencing (NGS) Solution Area Served and Its Competitors
Table 67. Roche Holding Next Generation Sequencing (NGS) Solution Product Offered
Table 68. Roche Holding Next Generation Sequencing (NGS) Solution Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 69. Roche Holding Main Business
Table 70. Roche Holding Latest Developments
Table 71. Agilent Technologies Details, Company Type, Next Generation Sequencing (NGS) Solution Area Served and Its Competitors
Table 72. Agilent Technologies Next Generation Sequencing (NGS) Solution Product Offered
Table 73. Agilent Technologies Next Generation Sequencing (NGS) Solution Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 74. Agilent Technologies Main Business
Table 75. Agilent Technologies Latest Developments
Table 76. Myriad Genetics Details, Company Type, Next Generation Sequencing (NGS) Solution Area Served and Its Competitors
Table 77. Myriad Genetics Next Generation Sequencing (NGS) Solution Product Offered
Table 78. Myriad Genetics Next Generation Sequencing (NGS) Solution Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 79. Myriad Genetics Main Business
Table 80. Myriad Genetics Latest Developments
Table 81. Foundation Medicine Details, Company Type, Next Generation Sequencing (NGS) Solution Area Served and Its Competitors
Table 82. Foundation Medicine Next Generation Sequencing (NGS) Solution Product Offered
Table 83. Foundation Medicine Next Generation Sequencing (NGS) Solution Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 84. Foundation Medicine Main Business
Table 85. Foundation Medicine Latest Developments
Table 86. Oxford Nanopore Technologies Details, Company Type, Next Generation Sequencing (NGS) Solution Area Served and Its Competitors
Table 87. Oxford Nanopore Technologies Next Generation Sequencing (NGS) Solution Product Offered
Table 88. Oxford Nanopore Technologies Next Generation Sequencing (NGS) Solution Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 89. Oxford Nanopore Technologies Main Business
Table 90. Oxford Nanopore Technologies Latest Developments
Table 91. Pacific Biosciences Details, Company Type, Next Generation Sequencing (NGS) Solution Area Served and Its Competitors
Table 92. Pacific Biosciences Next Generation Sequencing (NGS) Solution Product Offered
Table 93. Pacific Biosciences Next Generation Sequencing (NGS) Solution Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 94. Pacific Biosciences Main Business
Table 95. Pacific Biosciences Latest Developments
Table 96. Paradigm Diagnostics Details, Company Type, Next Generation Sequencing (NGS) Solution Area Served and Its Competitors
Table 97. Paradigm Diagnostics Next Generation Sequencing (NGS) Solution Product Offered
Table 98. Paradigm Diagnostics Next Generation Sequencing (NGS) Solution Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 99. Paradigm Diagnostics Main Business
Table 100. Paradigm Diagnostics Latest Developments
Table 101. BGI Group Details, Company Type, Next Generation Sequencing (NGS) Solution Area Served and Its Competitors
Table 102. BGI Group Next Generation Sequencing (NGS) Solution Product Offered
Table 103. BGI Group Next Generation Sequencing (NGS) Solution Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 104. BGI Group Main Business
Table 105. BGI Group Latest Developments
Table 106. Caris Life Sciences Details, Company Type, Next Generation Sequencing (NGS) Solution Area Served and Its Competitors
Table 107. Caris Life Sciences Next Generation Sequencing (NGS) Solution Product Offered
Table 108. Caris Life Sciences Next Generation Sequencing (NGS) Solution Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 109. Caris Life Sciences Main Business
Table 110. Caris Life Sciences Latest Developments
Table 111. Partek Details, Company Type, Next Generation Sequencing (NGS) Solution Area Served and Its Competitors
Table 112. Partek Next Generation Sequencing (NGS) Solution Product Offered
Table 113. Partek Next Generation Sequencing (NGS) Solution Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 114. Partek Main Business
Table 115. Partek Latest Developments
Table 116. Natera Details, Company Type, Next Generation Sequencing (NGS) Solution Area Served and Its Competitors
Table 117. Natera Next Generation Sequencing (NGS) Solution Product Offered
Table 118. Natera Next Generation Sequencing (NGS) Solution Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 119. Natera Main Business
Table 120. Natera Latest Developments
Table 121. LabCorp Details, Company Type, Next Generation Sequencing (NGS) Solution Area Served and Its Competitors
Table 122. LabCorp Next Generation Sequencing (NGS) Solution Product Offered
Table 123. LabCorp Next Generation Sequencing (NGS) Solution Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 124. LabCorp Main Business
Table 125. LabCorp Latest Developments
Table 126. Macrogen Details, Company Type, Next Generation Sequencing (NGS) Solution Area Served and Its Competitors
Table 127. Macrogen Next Generation Sequencing (NGS) Solution Product Offered
Table 128. Macrogen Next Generation Sequencing (NGS) Solution Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 129. Macrogen Main Business
Table 130. Macrogen Latest Developments
Table 131. Genotypic Technology Details, Company Type, Next Generation Sequencing (NGS) Solution Area Served and Its Competitors
Table 132. Genotypic Technology Next Generation Sequencing (NGS) Solution Product Offered
Table 133. Genotypic Technology Next Generation Sequencing (NGS) Solution Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 134. Genotypic Technology Main Business
Table 135. Genotypic Technology Latest Developments
Table 1. Next Generation Sequencing (NGS) Solution Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Next Generation Sequencing (NGS) Solution Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Whole Genome Sequencing
Table 4. Major Players of Whole Exome Sequencing
Table 5. Major Players of Targeted Sequencing and Resequencing Centrifuges
Table 6. Next Generation Sequencing (NGS) Solution Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 7. Global Next Generation Sequencing (NGS) Solution Market Size by Type (2021-2026) & ($ millions)
Table 8. Global Next Generation Sequencing (NGS) Solution Market Size Market Share by Type (2021-2026)
Table 9. Next Generation Sequencing (NGS) Solution Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 10. Global Next Generation Sequencing (NGS) Solution Market Size by Application (2021-2026) & ($ millions)
Table 11. Global Next Generation Sequencing (NGS) Solution Market Size Market Share by Application (2021-2026)
Table 12. Global Next Generation Sequencing (NGS) Solution Revenue by Player (2021-2026) & ($ millions)
Table 13. Global Next Generation Sequencing (NGS) Solution Revenue Market Share by Player (2021-2026)
Table 14. Next Generation Sequencing (NGS) Solution Key Players Head office and Products Offered
Table 15. Next Generation Sequencing (NGS) Solution Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Next Generation Sequencing (NGS) Solution Market Size by Region (2021-2026) & ($ millions)
Table 19. Global Next Generation Sequencing (NGS) Solution Market Size Market Share by Region (2021-2026)
Table 20. Global Next Generation Sequencing (NGS) Solution Revenue by Country/Region (2021-2026) & ($ millions)
Table 21. Global Next Generation Sequencing (NGS) Solution Revenue Market Share by Country/Region (2021-2026)
Table 22. Americas Next Generation Sequencing (NGS) Solution Market Size by Country (2021-2026) & ($ millions)
Table 23. Americas Next Generation Sequencing (NGS) Solution Market Size Market Share by Country (2021-2026)
Table 24. Americas Next Generation Sequencing (NGS) Solution Market Size by Type (2021-2026) & ($ millions)
Table 25. Americas Next Generation Sequencing (NGS) Solution Market Size Market Share by Type (2021-2026)
Table 26. Americas Next Generation Sequencing (NGS) Solution Market Size by Application (2021-2026) & ($ millions)
Table 27. Americas Next Generation Sequencing (NGS) Solution Market Size Market Share by Application (2021-2026)
Table 28. APAC Next Generation Sequencing (NGS) Solution Market Size by Region (2021-2026) & ($ millions)
Table 29. APAC Next Generation Sequencing (NGS) Solution Market Size Market Share by Region (2021-2026)
Table 30. APAC Next Generation Sequencing (NGS) Solution Market Size by Type (2021-2026) & ($ millions)
Table 31. APAC Next Generation Sequencing (NGS) Solution Market Size by Application (2021-2026) & ($ millions)
Table 32. Europe Next Generation Sequencing (NGS) Solution Market Size by Country (2021-2026) & ($ millions)
Table 33. Europe Next Generation Sequencing (NGS) Solution Market Size Market Share by Country (2021-2026)
Table 34. Europe Next Generation Sequencing (NGS) Solution Market Size by Type (2021-2026) & ($ millions)
Table 35. Europe Next Generation Sequencing (NGS) Solution Market Size by Application (2021-2026) & ($ millions)
Table 36. Middle East & Africa Next Generation Sequencing (NGS) Solution Market Size by Region (2021-2026) & ($ millions)
Table 37. Middle East & Africa Next Generation Sequencing (NGS) Solution Market Size by Type (2021-2026) & ($ millions)
Table 38. Middle East & Africa Next Generation Sequencing (NGS) Solution Market Size by Application (2021-2026) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Next Generation Sequencing (NGS) Solution
Table 40. Key Market Challenges & Risks of Next Generation Sequencing (NGS) Solution
Table 41. Key Industry Trends of Next Generation Sequencing (NGS) Solution
Table 42. Global Next Generation Sequencing (NGS) Solution Market Size Forecast by Region (2027-2032) & ($ millions)
Table 43. Global Next Generation Sequencing (NGS) Solution Market Size Market Share Forecast by Region (2027-2032)
Table 44. Global Next Generation Sequencing (NGS) Solution Market Size Forecast by Type (2027-2032) & ($ millions)
Table 45. Global Next Generation Sequencing (NGS) Solution Market Size Forecast by Application (2027-2032) & ($ millions)
Table 46. Eurofins Scientific Details, Company Type, Next Generation Sequencing (NGS) Solution Area Served and Its Competitors
Table 47. Eurofins Scientific Next Generation Sequencing (NGS) Solution Product Offered
Table 48. Eurofins Scientific Next Generation Sequencing (NGS) Solution Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 49. Eurofins Scientific Main Business
Table 50. Eurofins Scientific Latest Developments
Table 51. Illumina Details, Company Type, Next Generation Sequencing (NGS) Solution Area Served and Its Competitors
Table 52. Illumina Next Generation Sequencing (NGS) Solution Product Offered
Table 53. Illumina Next Generation Sequencing (NGS) Solution Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 54. Illumina Main Business
Table 55. Illumina Latest Developments
Table 56. PerkinElmer Details, Company Type, Next Generation Sequencing (NGS) Solution Area Served and Its Competitors
Table 57. PerkinElmer Next Generation Sequencing (NGS) Solution Product Offered
Table 58. PerkinElmer Next Generation Sequencing (NGS) Solution Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 59. PerkinElmer Main Business
Table 60. PerkinElmer Latest Developments
Table 61. Thermo Fisher Scientific Details, Company Type, Next Generation Sequencing (NGS) Solution Area Served and Its Competitors
Table 62. Thermo Fisher Scientific Next Generation Sequencing (NGS) Solution Product Offered
Table 63. Thermo Fisher Scientific Next Generation Sequencing (NGS) Solution Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 64. Thermo Fisher Scientific Main Business
Table 65. Thermo Fisher Scientific Latest Developments
Table 66. Roche Holding Details, Company Type, Next Generation Sequencing (NGS) Solution Area Served and Its Competitors
Table 67. Roche Holding Next Generation Sequencing (NGS) Solution Product Offered
Table 68. Roche Holding Next Generation Sequencing (NGS) Solution Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 69. Roche Holding Main Business
Table 70. Roche Holding Latest Developments
Table 71. Agilent Technologies Details, Company Type, Next Generation Sequencing (NGS) Solution Area Served and Its Competitors
Table 72. Agilent Technologies Next Generation Sequencing (NGS) Solution Product Offered
Table 73. Agilent Technologies Next Generation Sequencing (NGS) Solution Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 74. Agilent Technologies Main Business
Table 75. Agilent Technologies Latest Developments
Table 76. Myriad Genetics Details, Company Type, Next Generation Sequencing (NGS) Solution Area Served and Its Competitors
Table 77. Myriad Genetics Next Generation Sequencing (NGS) Solution Product Offered
Table 78. Myriad Genetics Next Generation Sequencing (NGS) Solution Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 79. Myriad Genetics Main Business
Table 80. Myriad Genetics Latest Developments
Table 81. Foundation Medicine Details, Company Type, Next Generation Sequencing (NGS) Solution Area Served and Its Competitors
Table 82. Foundation Medicine Next Generation Sequencing (NGS) Solution Product Offered
Table 83. Foundation Medicine Next Generation Sequencing (NGS) Solution Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 84. Foundation Medicine Main Business
Table 85. Foundation Medicine Latest Developments
Table 86. Oxford Nanopore Technologies Details, Company Type, Next Generation Sequencing (NGS) Solution Area Served and Its Competitors
Table 87. Oxford Nanopore Technologies Next Generation Sequencing (NGS) Solution Product Offered
Table 88. Oxford Nanopore Technologies Next Generation Sequencing (NGS) Solution Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 89. Oxford Nanopore Technologies Main Business
Table 90. Oxford Nanopore Technologies Latest Developments
Table 91. Pacific Biosciences Details, Company Type, Next Generation Sequencing (NGS) Solution Area Served and Its Competitors
Table 92. Pacific Biosciences Next Generation Sequencing (NGS) Solution Product Offered
Table 93. Pacific Biosciences Next Generation Sequencing (NGS) Solution Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 94. Pacific Biosciences Main Business
Table 95. Pacific Biosciences Latest Developments
Table 96. Paradigm Diagnostics Details, Company Type, Next Generation Sequencing (NGS) Solution Area Served and Its Competitors
Table 97. Paradigm Diagnostics Next Generation Sequencing (NGS) Solution Product Offered
Table 98. Paradigm Diagnostics Next Generation Sequencing (NGS) Solution Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 99. Paradigm Diagnostics Main Business
Table 100. Paradigm Diagnostics Latest Developments
Table 101. BGI Group Details, Company Type, Next Generation Sequencing (NGS) Solution Area Served and Its Competitors
Table 102. BGI Group Next Generation Sequencing (NGS) Solution Product Offered
Table 103. BGI Group Next Generation Sequencing (NGS) Solution Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 104. BGI Group Main Business
Table 105. BGI Group Latest Developments
Table 106. Caris Life Sciences Details, Company Type, Next Generation Sequencing (NGS) Solution Area Served and Its Competitors
Table 107. Caris Life Sciences Next Generation Sequencing (NGS) Solution Product Offered
Table 108. Caris Life Sciences Next Generation Sequencing (NGS) Solution Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 109. Caris Life Sciences Main Business
Table 110. Caris Life Sciences Latest Developments
Table 111. Partek Details, Company Type, Next Generation Sequencing (NGS) Solution Area Served and Its Competitors
Table 112. Partek Next Generation Sequencing (NGS) Solution Product Offered
Table 113. Partek Next Generation Sequencing (NGS) Solution Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 114. Partek Main Business
Table 115. Partek Latest Developments
Table 116. Natera Details, Company Type, Next Generation Sequencing (NGS) Solution Area Served and Its Competitors
Table 117. Natera Next Generation Sequencing (NGS) Solution Product Offered
Table 118. Natera Next Generation Sequencing (NGS) Solution Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 119. Natera Main Business
Table 120. Natera Latest Developments
Table 121. LabCorp Details, Company Type, Next Generation Sequencing (NGS) Solution Area Served and Its Competitors
Table 122. LabCorp Next Generation Sequencing (NGS) Solution Product Offered
Table 123. LabCorp Next Generation Sequencing (NGS) Solution Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 124. LabCorp Main Business
Table 125. LabCorp Latest Developments
Table 126. Macrogen Details, Company Type, Next Generation Sequencing (NGS) Solution Area Served and Its Competitors
Table 127. Macrogen Next Generation Sequencing (NGS) Solution Product Offered
Table 128. Macrogen Next Generation Sequencing (NGS) Solution Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 129. Macrogen Main Business
Table 130. Macrogen Latest Developments
Table 131. Genotypic Technology Details, Company Type, Next Generation Sequencing (NGS) Solution Area Served and Its Competitors
Table 132. Genotypic Technology Next Generation Sequencing (NGS) Solution Product Offered
Table 133. Genotypic Technology Next Generation Sequencing (NGS) Solution Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 134. Genotypic Technology Main Business
Table 135. Genotypic Technology Latest Developments
LIST OF FIGURES
Figure 1. Next Generation Sequencing (NGS) Solution Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Next Generation Sequencing (NGS) Solution Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Next Generation Sequencing (NGS) Solution Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Next Generation Sequencing (NGS) Solution Sales Market Share by Country/Region (2025)
Figure 8. Next Generation Sequencing (NGS) Solution Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Next Generation Sequencing (NGS) Solution Market Size Market Share by Type in 2025
Figure 10. Next Generation Sequencing (NGS) Solution in Sporadic Cancer
Figure 11. Global Next Generation Sequencing (NGS) Solution Market: Sporadic Cancer (2021-2026) & ($ millions)
Figure 12. Next Generation Sequencing (NGS) Solution in Inherited Cancer
Figure 13. Global Next Generation Sequencing (NGS) Solution Market: Inherited Cancer (2021-2026) & ($ millions)
Figure 14. Next Generation Sequencing (NGS) Solution in Companion Diagnostics
Figure 15. Global Next Generation Sequencing (NGS) Solution Market: Companion Diagnostics (2021-2026) & ($ millions)
Figure 16. Next Generation Sequencing (NGS) Solution in Others
Figure 17. Global Next Generation Sequencing (NGS) Solution Market: Others (2021-2026) & ($ millions)
Figure 18. Global Next Generation Sequencing (NGS) Solution Market Size Market Share by Application in 2025
Figure 19. Global Next Generation Sequencing (NGS) Solution Revenue Market Share by Player in 2025
Figure 20. Global Next Generation Sequencing (NGS) Solution Market Size Market Share by Region (2021-2026)
Figure 21. Americas Next Generation Sequencing (NGS) Solution Market Size 2021-2026 ($ millions)
Figure 22. APAC Next Generation Sequencing (NGS) Solution Market Size 2021-2026 ($ millions)
Figure 23. Europe Next Generation Sequencing (NGS) Solution Market Size 2021-2026 ($ millions)
Figure 24. Middle East & Africa Next Generation Sequencing (NGS) Solution Market Size 2021-2026 ($ millions)
Figure 25. Americas Next Generation Sequencing (NGS) Solution Value Market Share by Country in 2025
Figure 26. United States Next Generation Sequencing (NGS) Solution Market Size Growth 2021-2026 ($ millions)
Figure 27. Canada Next Generation Sequencing (NGS) Solution Market Size Growth 2021-2026 ($ millions)
Figure 28. Mexico Next Generation Sequencing (NGS) Solution Market Size Growth 2021-2026 ($ millions)
Figure 29. Brazil Next Generation Sequencing (NGS) Solution Market Size Growth 2021-2026 ($ millions)
Figure 30. APAC Next Generation Sequencing (NGS) Solution Market Size Market Share by Region in 2025
Figure 31. APAC Next Generation Sequencing (NGS) Solution Market Size Market Share by Type (2021-2026)
Figure 32. APAC Next Generation Sequencing (NGS) Solution Market Size Market Share by Application (2021-2026)
Figure 33. China Next Generation Sequencing (NGS) Solution Market Size Growth 2021-2026 ($ millions)
Figure 34. Japan Next Generation Sequencing (NGS) Solution Market Size Growth 2021-2026 ($ millions)
Figure 35. South Korea Next Generation Sequencing (NGS) Solution Market Size Growth 2021-2026 ($ millions)
Figure 36. Southeast Asia Next Generation Sequencing (NGS) Solution Market Size Growth 2021-2026 ($ millions)
Figure 37. India Next Generation Sequencing (NGS) Solution Market Size Growth 2021-2026 ($ millions)
Figure 38. Australia Next Generation Sequencing (NGS) Solution Market Size Growth 2021-2026 ($ millions)
Figure 39. Europe Next Generation Sequencing (NGS) Solution Market Size Market Share by Country in 2025
Figure 40. Europe Next Generation Sequencing (NGS) Solution Market Size Market Share by Type (2021-2026)
Figure 41. Europe Next Generation Sequencing (NGS) Solution Market Size Market Share by Application (2021-2026)
Figure 42. Germany Next Generation Sequencing (NGS) Solution Market Size Growth 2021-2026 ($ millions)
Figure 43. France Next Generation Sequencing (NGS) Solution Market Size Growth 2021-2026 ($ millions)
Figure 44. UK Next Generation Sequencing (NGS) Solution Market Size Growth 2021-2026 ($ millions)
Figure 45. Italy Next Generation Sequencing (NGS) Solution Market Size Growth 2021-2026 ($ millions)
Figure 46. Russia Next Generation Sequencing (NGS) Solution Market Size Growth 2021-2026 ($ millions)
Figure 47. Middle East & Africa Next Generation Sequencing (NGS) Solution Market Size Market Share by Region (2021-2026)
Figure 48. Middle East & Africa Next Generation Sequencing (NGS) Solution Market Size Market Share by Type (2021-2026)
Figure 49. Middle East & Africa Next Generation Sequencing (NGS) Solution Market Size Market Share by Application (2021-2026)
Figure 50. Egypt Next Generation Sequencing (NGS) Solution Market Size Growth 2021-2026 ($ millions)
Figure 51. South Africa Next Generation Sequencing (NGS) Solution Market Size Growth 2021-2026 ($ millions)
Figure 52. Israel Next Generation Sequencing (NGS) Solution Market Size Growth 2021-2026 ($ millions)
Figure 53. Turkey Next Generation Sequencing (NGS) Solution Market Size Growth 2021-2026 ($ millions)
Figure 54. GCC Countries Next Generation Sequencing (NGS) Solution Market Size Growth 2021-2026 ($ millions)
Figure 55. Americas Next Generation Sequencing (NGS) Solution Market Size 2027-2032 ($ millions)
Figure 56. APAC Next Generation Sequencing (NGS) Solution Market Size 2027-2032 ($ millions)
Figure 57. Europe Next Generation Sequencing (NGS) Solution Market Size 2027-2032 ($ millions)
Figure 58. Middle East & Africa Next Generation Sequencing (NGS) Solution Market Size 2027-2032 ($ millions)
Figure 59. United States Next Generation Sequencing (NGS) Solution Market Size 2027-2032 ($ millions)
Figure 60. Canada Next Generation Sequencing (NGS) Solution Market Size 2027-2032 ($ millions)
Figure 61. Mexico Next Generation Sequencing (NGS) Solution Market Size 2027-2032 ($ millions)
Figure 62. Brazil Next Generation Sequencing (NGS) Solution Market Size 2027-2032 ($ millions)
Figure 63. China Next Generation Sequencing (NGS) Solution Market Size 2027-2032 ($ millions)
Figure 64. Japan Next Generation Sequencing (NGS) Solution Market Size 2027-2032 ($ millions)
Figure 65. Korea Next Generation Sequencing (NGS) Solution Market Size 2027-2032 ($ millions)
Figure 66. Southeast Asia Next Generation Sequencing (NGS) Solution Market Size 2027-2032 ($ millions)
Figure 67. India Next Generation Sequencing (NGS) Solution Market Size 2027-2032 ($ millions)
Figure 68. Australia Next Generation Sequencing (NGS) Solution Market Size 2027-2032 ($ millions)
Figure 69. Germany Next Generation Sequencing (NGS) Solution Market Size 2027-2032 ($ millions)
Figure 70. France Next Generation Sequencing (NGS) Solution Market Size 2027-2032 ($ millions)
Figure 71. UK Next Generation Sequencing (NGS) Solution Market Size 2027-2032 ($ millions)
Figure 72. Italy Next Generation Sequencing (NGS) Solution Market Size 2027-2032 ($ millions)
Figure 73. Russia Next Generation Sequencing (NGS) Solution Market Size 2027-2032 ($ millions)
Figure 74. Egypt Next Generation Sequencing (NGS) Solution Market Size 2027-2032 ($ millions)
Figure 75. South Africa Next Generation Sequencing (NGS) Solution Market Size 2027-2032 ($ millions)
Figure 76. Israel Next Generation Sequencing (NGS) Solution Market Size 2027-2032 ($ millions)
Figure 77. Turkey Next Generation Sequencing (NGS) Solution Market Size 2027-2032 ($ millions)
Figure 78. Global Next Generation Sequencing (NGS) Solution Market Size Market Share Forecast by Type (2027-2032)
Figure 79. Global Next Generation Sequencing (NGS) Solution Market Size Market Share Forecast by Application (2027-2032)
Figure 80. GCC Countries Next Generation Sequencing (NGS) Solution Market Size 2027-2032 ($ millions)
Figure 1. Next Generation Sequencing (NGS) Solution Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Next Generation Sequencing (NGS) Solution Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Next Generation Sequencing (NGS) Solution Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Next Generation Sequencing (NGS) Solution Sales Market Share by Country/Region (2025)
Figure 8. Next Generation Sequencing (NGS) Solution Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Next Generation Sequencing (NGS) Solution Market Size Market Share by Type in 2025
Figure 10. Next Generation Sequencing (NGS) Solution in Sporadic Cancer
Figure 11. Global Next Generation Sequencing (NGS) Solution Market: Sporadic Cancer (2021-2026) & ($ millions)
Figure 12. Next Generation Sequencing (NGS) Solution in Inherited Cancer
Figure 13. Global Next Generation Sequencing (NGS) Solution Market: Inherited Cancer (2021-2026) & ($ millions)
Figure 14. Next Generation Sequencing (NGS) Solution in Companion Diagnostics
Figure 15. Global Next Generation Sequencing (NGS) Solution Market: Companion Diagnostics (2021-2026) & ($ millions)
Figure 16. Next Generation Sequencing (NGS) Solution in Others
Figure 17. Global Next Generation Sequencing (NGS) Solution Market: Others (2021-2026) & ($ millions)
Figure 18. Global Next Generation Sequencing (NGS) Solution Market Size Market Share by Application in 2025
Figure 19. Global Next Generation Sequencing (NGS) Solution Revenue Market Share by Player in 2025
Figure 20. Global Next Generation Sequencing (NGS) Solution Market Size Market Share by Region (2021-2026)
Figure 21. Americas Next Generation Sequencing (NGS) Solution Market Size 2021-2026 ($ millions)
Figure 22. APAC Next Generation Sequencing (NGS) Solution Market Size 2021-2026 ($ millions)
Figure 23. Europe Next Generation Sequencing (NGS) Solution Market Size 2021-2026 ($ millions)
Figure 24. Middle East & Africa Next Generation Sequencing (NGS) Solution Market Size 2021-2026 ($ millions)
Figure 25. Americas Next Generation Sequencing (NGS) Solution Value Market Share by Country in 2025
Figure 26. United States Next Generation Sequencing (NGS) Solution Market Size Growth 2021-2026 ($ millions)
Figure 27. Canada Next Generation Sequencing (NGS) Solution Market Size Growth 2021-2026 ($ millions)
Figure 28. Mexico Next Generation Sequencing (NGS) Solution Market Size Growth 2021-2026 ($ millions)
Figure 29. Brazil Next Generation Sequencing (NGS) Solution Market Size Growth 2021-2026 ($ millions)
Figure 30. APAC Next Generation Sequencing (NGS) Solution Market Size Market Share by Region in 2025
Figure 31. APAC Next Generation Sequencing (NGS) Solution Market Size Market Share by Type (2021-2026)
Figure 32. APAC Next Generation Sequencing (NGS) Solution Market Size Market Share by Application (2021-2026)
Figure 33. China Next Generation Sequencing (NGS) Solution Market Size Growth 2021-2026 ($ millions)
Figure 34. Japan Next Generation Sequencing (NGS) Solution Market Size Growth 2021-2026 ($ millions)
Figure 35. South Korea Next Generation Sequencing (NGS) Solution Market Size Growth 2021-2026 ($ millions)
Figure 36. Southeast Asia Next Generation Sequencing (NGS) Solution Market Size Growth 2021-2026 ($ millions)
Figure 37. India Next Generation Sequencing (NGS) Solution Market Size Growth 2021-2026 ($ millions)
Figure 38. Australia Next Generation Sequencing (NGS) Solution Market Size Growth 2021-2026 ($ millions)
Figure 39. Europe Next Generation Sequencing (NGS) Solution Market Size Market Share by Country in 2025
Figure 40. Europe Next Generation Sequencing (NGS) Solution Market Size Market Share by Type (2021-2026)
Figure 41. Europe Next Generation Sequencing (NGS) Solution Market Size Market Share by Application (2021-2026)
Figure 42. Germany Next Generation Sequencing (NGS) Solution Market Size Growth 2021-2026 ($ millions)
Figure 43. France Next Generation Sequencing (NGS) Solution Market Size Growth 2021-2026 ($ millions)
Figure 44. UK Next Generation Sequencing (NGS) Solution Market Size Growth 2021-2026 ($ millions)
Figure 45. Italy Next Generation Sequencing (NGS) Solution Market Size Growth 2021-2026 ($ millions)
Figure 46. Russia Next Generation Sequencing (NGS) Solution Market Size Growth 2021-2026 ($ millions)
Figure 47. Middle East & Africa Next Generation Sequencing (NGS) Solution Market Size Market Share by Region (2021-2026)
Figure 48. Middle East & Africa Next Generation Sequencing (NGS) Solution Market Size Market Share by Type (2021-2026)
Figure 49. Middle East & Africa Next Generation Sequencing (NGS) Solution Market Size Market Share by Application (2021-2026)
Figure 50. Egypt Next Generation Sequencing (NGS) Solution Market Size Growth 2021-2026 ($ millions)
Figure 51. South Africa Next Generation Sequencing (NGS) Solution Market Size Growth 2021-2026 ($ millions)
Figure 52. Israel Next Generation Sequencing (NGS) Solution Market Size Growth 2021-2026 ($ millions)
Figure 53. Turkey Next Generation Sequencing (NGS) Solution Market Size Growth 2021-2026 ($ millions)
Figure 54. GCC Countries Next Generation Sequencing (NGS) Solution Market Size Growth 2021-2026 ($ millions)
Figure 55. Americas Next Generation Sequencing (NGS) Solution Market Size 2027-2032 ($ millions)
Figure 56. APAC Next Generation Sequencing (NGS) Solution Market Size 2027-2032 ($ millions)
Figure 57. Europe Next Generation Sequencing (NGS) Solution Market Size 2027-2032 ($ millions)
Figure 58. Middle East & Africa Next Generation Sequencing (NGS) Solution Market Size 2027-2032 ($ millions)
Figure 59. United States Next Generation Sequencing (NGS) Solution Market Size 2027-2032 ($ millions)
Figure 60. Canada Next Generation Sequencing (NGS) Solution Market Size 2027-2032 ($ millions)
Figure 61. Mexico Next Generation Sequencing (NGS) Solution Market Size 2027-2032 ($ millions)
Figure 62. Brazil Next Generation Sequencing (NGS) Solution Market Size 2027-2032 ($ millions)
Figure 63. China Next Generation Sequencing (NGS) Solution Market Size 2027-2032 ($ millions)
Figure 64. Japan Next Generation Sequencing (NGS) Solution Market Size 2027-2032 ($ millions)
Figure 65. Korea Next Generation Sequencing (NGS) Solution Market Size 2027-2032 ($ millions)
Figure 66. Southeast Asia Next Generation Sequencing (NGS) Solution Market Size 2027-2032 ($ millions)
Figure 67. India Next Generation Sequencing (NGS) Solution Market Size 2027-2032 ($ millions)
Figure 68. Australia Next Generation Sequencing (NGS) Solution Market Size 2027-2032 ($ millions)
Figure 69. Germany Next Generation Sequencing (NGS) Solution Market Size 2027-2032 ($ millions)
Figure 70. France Next Generation Sequencing (NGS) Solution Market Size 2027-2032 ($ millions)
Figure 71. UK Next Generation Sequencing (NGS) Solution Market Size 2027-2032 ($ millions)
Figure 72. Italy Next Generation Sequencing (NGS) Solution Market Size 2027-2032 ($ millions)
Figure 73. Russia Next Generation Sequencing (NGS) Solution Market Size 2027-2032 ($ millions)
Figure 74. Egypt Next Generation Sequencing (NGS) Solution Market Size 2027-2032 ($ millions)
Figure 75. South Africa Next Generation Sequencing (NGS) Solution Market Size 2027-2032 ($ millions)
Figure 76. Israel Next Generation Sequencing (NGS) Solution Market Size 2027-2032 ($ millions)
Figure 77. Turkey Next Generation Sequencing (NGS) Solution Market Size 2027-2032 ($ millions)
Figure 78. Global Next Generation Sequencing (NGS) Solution Market Size Market Share Forecast by Type (2027-2032)
Figure 79. Global Next Generation Sequencing (NGS) Solution Market Size Market Share Forecast by Application (2027-2032)
Figure 80. GCC Countries Next Generation Sequencing (NGS) Solution Market Size 2027-2032 ($ millions)
